Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gliosarcoma × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 103 Lymphoma 67 Lymphoma, Large B-Cell, Diffuse 48 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Sarcoma 33 Lymphoma, Non-Hodgkin 29 Hodgkin Disease 27 Leukemia 23 Burkitt Lymphoma 22 Neoplasms 19 Lymphoma, Mantle-Cell 18 Triple Negative Breast Neoplasms 15 Multiple Myeloma 15 Lymphoma, Follicular 15 Lymphoma, B-Cell 14 Lymphoma, Large-Cell, Anaplastic 12 Carcinoma, Hepatocellular 12 Breast Neoplasms, Male 11 Neuroblastoma 10 Recurrence 9 Ovarian Neoplasms 9 Neoplasm Metastasis 9 Inflammatory Breast Neoplasms 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, T-Cell, Peripheral 8 Lymphoma, T-Cell 8 Osteosarcoma 7 Fallopian Tube Neoplasms 7 Urinary Bladder Neoplasms 6 Liposarcoma 6

Interventions

Temozolomide 52 Bevacizumab 33 Radiotherapy 26 Radiation 12 Erlotinib Hydrochloride 12 Radiotherapy, Intensity-Modulated 8 Radiotherapy, Conformal 8 Irinotecan 6 Vorinostat 5 Sorafenib 5 Sirolimus 5 temsirolimus 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 Carmustine 4 veliparib 3 plerixafor 3 carmustine, poliferprosan 20 drug combination 3 Radiosurgery 3 Everolimus 3 Dasatinib 3 Bortezomib 3 vandetanib 2 tandutinib 2 sargramostim 2 poly ICLC 2 pembrolizumab 2 pazopanib 2 ferric pyrophosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡